The Turkish journal of pediatrics, cilt.62, ss.167-174, 2020 (SCI-Expanded)
Background and objectives. The aim of this observational retrospective cohort study was to demonstrate indications and response rates of the patients with pediatric rheumatic diseases that used canakinumab.